Lupin Limited has informed the Exchange regarding a press release dated August 25, 2023, titled "Lupin Receives Approval from U.S. FDA for Pirfenidone Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated August 25, 2023, titled "Lupin Receives Approval from U.S. FDA for Pirfenidone Tablets.".